Related Experiment Video
Updated: May 30, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Using a quality improvement process to create measurable improvement in care delivery for acute stroke
Rhonda Whiteman1, Linda Gould, Wieslaw Oczkowski
1Hamilton Health Sciences, Hamilton, Ontario.
Abstract:
The introduction of thrombolytic therapy has revolutionized the management of acute ischemic stroke, and it has now been conclusively established that tissue plasminogen activator (t-PA) given within 4.5 hours of stroke onset both limits irreversible ischemic neuronal damage by establishing reperfusion of the penumbra and improves outcomes for patients who have undergone stroke. As a regional stroke centre, Hamilton Health Services (HHS) seeks to ensure it meets guidelines and readiness criteria in acute stroke care. This article discusses how HHS developed and used a quality improvement process to ensure all patients receive thrombosis therapy within 60 minutes of arrival at hospital.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Introduction to Statistical Process Control
Atherosclerosis IV: Nursing Management
